NCT04752020View on ClinicalTrials.gov

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 28, 2021

Primary Completion Date

June 28, 2023

Study Completion Date

December 30, 2023

Conditions
Fuchs' Endothelial Dystrophy
Interventions
DRUG

Netarsudil Ophthalmic

Use of netarsudil after Descemetorhexis without endothelial keratoplasty

Trial Locations (1)

02127

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT04752020 - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty | Biotech Hunter | Biotech Hunter